{"id":55211,"date":"2016-02-04T17:28:00","date_gmt":"2016-02-04T21:28:00","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?p=55211"},"modified":"2023-09-06T15:26:09","modified_gmt":"2023-09-06T20:26:09","slug":"tom-fulmer-hired-as-national-business-development-manager-of-national-drug-screening","status":"publish","type":"post","link":"https:\/\/www.nationaldrugscreening.com\/blogs\/tom-fulmer-hired-as-national-business-development-manager-of-national-drug-screening\/","title":{"rendered":"Tom Fulmer Hired as National Business Development Manager of National Drug Screening"},"content":{"rendered":"\r\n<p><em>Melbourne, FL<\/em>\u2013 National Drug Screening, Inc. announced the hiring of Tom Fulmer as National Business Development Manager. Fulmer, formally a Professional Speaker, Trainer, and business development consultant will focus on continuing to build the National Drug Screening brand and service offerings throughout the United States and Puerto Rico.\u00a0 Tom will be based out of Melbourne, FL\u00a0 and will report to Joe Reilly, President of National Drug Screening and former Chairman of DATIA (Drug &amp; Alcohol Testing Industry Association merged with\u00a0<a href=\"https:\/\/ndasa.com\/\" target=\"_blank\" rel=\"noopener\">NDASA<\/a> in 2023)<\/p>\r\n\r\n\r\n\r\n<figure class=\"wp-block-table\">\r\n<table>\r\n<tbody>\r\n<tr>\r\n<td>\u201cI have known Tom for years as a fellow business owner<br \/>and active member of the business community; Tom is a<br \/>talented and experienced professional and we are\u00a0<br \/>delighted to have him join us at National Drug Screening.,\u201d\u00a0<br \/>stated Joe Reilly, President of National Drug Screening, Inc.<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<\/figure>\r\n\r\n\r\n\r\n<p>Fulmer has over 20 years of business development experience and started his business career as a Tennis Pro running a\u00a0Tennis Center in Tuscaloosa, AL. After retiring from tennis in 2002, he got into the mortgage business and ran his own mortgage company for 3 years before launching the Thomas Fulmer Company in 2007. There he followed his passion of helping others develop personally and professional though his work as a professional speaker, corporate trainer, and consultant.<\/p>\r\n\r\n\r\n\r\n<p>In 2015, He was ready for another change and joining the team at National Drug Screening turned out to be the perfect fit. Tom lives in Melbourne, FL with his wife, Amy, and their 2 dogs.<\/p>\r\n\r\n\r\n\r\n<p><strong><em>About National Drug Screening<\/em><\/strong><\/p>\r\n\r\n\r\n\r\n<p><em>A privately owned company based in Melbourne, FL, National Drug Screening has experienced dramatic growth over the past 12 months.\u00a0<\/em><em>NDS offers not only drug testing services for both individuals and small to large companies across the United States and Puerto Rico but also provides MRO, software, and training for other drug testing companies and c\/TPA\u2019s. All drug and alcohol testing programs are designed to be in compliance with Federal and State laws, to reduce the employer\u2019s exposure to liability, and to help attract and retain more productive employees.\u00a0For additional information, call 866-843-4545 or visit www.nationaldrugscreening.com.<\/em><\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>Melbourne, FL\u2013 National Drug Screening, Inc. announced the hiring of Tom Fulmer as National Business Development Manager. Fulmer, formally a Professional Speaker, Trainer, and business development consultant will focus on continuing to build the National Drug Screening brand and service offerings throughout the United States and Puerto Rico.\u00a0 Tom will be based out of Melbourne, [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":1036,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/55211"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=55211"}],"version-history":[{"count":1,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/55211\/revisions"}],"predecessor-version":[{"id":118391,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/55211\/revisions\/118391"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/1036"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=55211"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=55211"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=55211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}